In Alzheimer’s disease, SIRT1 prevented axonal degeneration and neurodegeneration, and also reduced tau proteins by deacetylating tau and reducing the production of beta-amyloids [54]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.